| UniProt ID | DHYS_HUMAN | |
|---|---|---|
| UniProt AC | P49366 | |
| Protein Name | Deoxyhypusine synthase | |
| Gene Name | DHPS | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 369 | |
| Subcellular Localization | ||
| Protein Description | Catalyzes the NAD-dependent oxidative cleavage of spermidine and the subsequent transfer of the butylamine moiety of spermidine to the epsilon-amino group of a critical lysine residue of the eIF-5A precursor protein to form the intermediate deoxyhypusine residue. This is the first step of the post-translational modification of that lysine into an unusual amino acid residue named hypusine. Hypusination is unique to mature eIF-5A factor and is essential for its function.. | |
| Protein Sequence | MEGSLEREAPAGALAAVLKHSSTLPPESTQVRGYDFNRGVNYRALLEAFGTTGFQATNFGRAVQQVNAMIEKKLEPLSQDEDQHADLTQSRRPLTSCTIFLGYTSNLISSGIRETIRYLVQHNMVDVLVTTAGGVEEDLIKCLAPTYLGEFSLRGKELRENGINRIGNLLVPNENYCKFEDWLMPILDQMVMEQNTEGVKWTPSKMIARLGKEINNPESVYYWAQKNHIPVFSPALTDGSLGDMIFFHSYKNPGLVLDIVEDLRLINTQAIFAKCTGMIILGGGVVKHHIANANLMRNGADYAVYINTAQEFDGSDSGARPDEAVSWGKIRVDAQPVKVYADASLVFPLLVAETFAQKMDAFMHEKNED | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MEGSLERE -------CCCCCCCC | 13.69 | - | |
| 4 | Phosphorylation | ----MEGSLEREAPA ----CCCCCCCCCCH | 17.47 | 28464451 | |
| 19 | Ubiquitination | GALAAVLKHSSTLPP HHHHHHHHCCCCCCC | 34.54 | 21890473 | |
| 19 (in isoform 1) | Ubiquitination | - | 34.54 | 21890473 | |
| 22 (in isoform 3) | Phosphorylation | - | 33.41 | - | |
| 22 | Phosphorylation | AAVLKHSSTLPPEST HHHHHCCCCCCCCCC | 33.41 | - | |
| 36 (in isoform 3) | Phosphorylation | - | 5.17 | 25849741 | |
| 38 | Methylation | VRGYDFNRGVNYRAL CCCEECCCCCCHHHH | 50.89 | - | |
| 48 | Phosphorylation | NYRALLEAFGTTGFQ CHHHHHHHHCCCCCC | 14.24 | - | |
| 69 | Sulfoxidation | AVQQVNAMIEKKLEP HHHHHHHHHHHHCCC | 3.24 | 21406390 | |
| 72 (in isoform 1) | Ubiquitination | - | 52.30 | 21890473 | |
| 72 | Ubiquitination | QVNAMIEKKLEPLSQ HHHHHHHHHCCCCCC | 52.30 | 21906983 | |
| 72 (in isoform 2) | Ubiquitination | - | 52.30 | 21890473 | |
| 73 (in isoform 2) | Ubiquitination | - | 45.34 | 21890473 | |
| 73 (in isoform 1) | Ubiquitination | - | 45.34 | 21890473 | |
| 73 | Ubiquitination | VNAMIEKKLEPLSQD HHHHHHHHCCCCCCC | 45.34 | 73 | |
| 78 | Phosphorylation | EKKLEPLSQDEDQHA HHHCCCCCCCHHHCC | 46.42 | 17525332 | |
| 88 | Phosphorylation | EDQHADLTQSRRPLT HHHCCCCHHCCCCCC | 25.66 | 17525332 | |
| 90 | Phosphorylation | QHADLTQSRRPLTSC HCCCCHHCCCCCCCC | 25.64 | 23312004 | |
| 105 | Phosphorylation | TIFLGYTSNLISSGI EEEEECHHHHHHHCH | 22.58 | - | |
| 156 | Ubiquitination | GEFSLRGKELRENGI EECCCCCHHHHHCCC | 47.33 | - | |
| 196 | Phosphorylation | QMVMEQNTEGVKWTP HHHHHCCCCCCCCCH | 33.53 | 23532336 | |
| 205 (in isoform 1) | Ubiquitination | - | 35.21 | 21890473 | |
| 205 | Ubiquitination | GVKWTPSKMIARLGK CCCCCHHHHHHHHCH | 35.21 | 21906983 | |
| 205 (in isoform 2) | Ubiquitination | - | 35.21 | 21890473 | |
| 212 (in isoform 2) | Ubiquitination | - | 61.07 | 21890473 | |
| 212 | Ubiquitination | KMIARLGKEINNPES HHHHHHCHHCCCHHH | 61.07 | 2190698 | |
| 212 (in isoform 1) | Ubiquitination | - | 61.07 | 21890473 | |
| 319 (in isoform 2) | Ubiquitination | - | 24.63 | 21890473 | |
| 329 | Ubiquitination | DEAVSWGKIRVDAQP CCCCCCCCEEECCCC | 22.53 | - | |
| 338 | Ubiquitination | RVDAQPVKVYADASL EECCCCEEEEECHHH | 35.89 | - | |
| 366 | Ubiquitination | MDAFMHEKNED---- HHHHHHHHCCC---- | 51.46 | - | |
| 366 (in isoform 1) | Ubiquitination | - | 51.46 | 21890473 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DHYS_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DHYS_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DHYS_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| NIF3L_HUMAN | NIF3L1 | physical | 16189514 | |
| NUD18_HUMAN | NUDT18 | physical | 16189514 | |
| IF5A2_HUMAN | EIF5A2 | physical | 16189514 | |
| RL9_HUMAN | RPL9 | physical | 16189514 | |
| ARP2_HUMAN | ACTR2 | physical | 22863883 | |
| ANKY2_HUMAN | ANKMY2 | physical | 22863883 | |
| AN32B_HUMAN | ANP32B | physical | 22863883 | |
| ARI1_HUMAN | ARIH1 | physical | 22863883 | |
| ARC1B_HUMAN | ARPC1B | physical | 22863883 | |
| PYRG2_HUMAN | CTPS2 | physical | 22863883 | |
| DPP8_HUMAN | DPP8 | physical | 22863883 | |
| HNRPF_HUMAN | HNRNPF | physical | 22863883 | |
| HSF1_HUMAN | HSF1 | physical | 22863883 | |
| PLIN3_HUMAN | PLIN3 | physical | 22863883 | |
| 2A5D_HUMAN | PPP2R5D | physical | 22863883 | |
| SRP09_HUMAN | SRP9 | physical | 22863883 | |
| SURF2_HUMAN | SURF2 | physical | 22863883 | |
| DHYS_HUMAN | DHPS | physical | 25416956 | |
| IF5A1_HUMAN | EIF5A | physical | 25416956 | |
| RB27B_HUMAN | RAB27B | physical | 25416956 | |
| REL_HUMAN | REL | physical | 25416956 | |
| RL9_HUMAN | RPL9 | physical | 25416956 | |
| ZN138_HUMAN | ZNF138 | physical | 25416956 | |
| VASH1_HUMAN | VASH1 | physical | 25416956 | |
| NTAQ1_HUMAN | WDYHV1 | physical | 25416956 | |
| IF5A2_HUMAN | EIF5A2 | physical | 25416956 | |
| BRCA1_HUMAN | BRCA1 | physical | 25184681 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-78 AND THR-88, AND MASSSPECTROMETRY. | |